Skip to main content
Erschienen in: Journal of Cancer Survivorship 2/2013

01.06.2013

Ductal carcinoma in situ (DCIS): posttreatment follow-up care among Latina and non-Latina White women

verfasst von: Mónica E. López, Celia P. Kaplan, Anna M. Nápoles, Jennifer C. Livaudais, E. Shelley Hwang, Susan L. Stewart, Joan Bloom, Leah Karliner

Erschienen in: Journal of Cancer Survivorship | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

There is a lack of information about posttreatment care among patients with ductal carcinoma in situ (DCIS). This study compares posttreatment care by ethnicity–language and physician specialty among Latina and White women with DCIS.

Methods

Latina and White women diagnosed with DCIS between 2002 and 2005 identified through the California Cancer Registry completed a telephone survey in 2006. Main outcomes were breast surveillance, lifestyle counseling, and follow-up physician specialty.

Key results

Of 742 women (396 White, 349 Latinas), most (90 %) had at least one clinical breast exam (CBE). Among women treated with breast-conserving surgery (BCS; N = 503), 76 % had received at least two mammograms. While 92 % of all women had follow-up with a breast specialist, Spanish-speaking Latinas had the lowest specialist follow-up rates (84 %) of all groups. Lifestyle counseling was low with only 53 % discussing exercise, 43 % weight, and 31 % alcohol in relation to their DCIS. In multivariable analysis, Spanish-speaking Latinas with BCS had lower odds of receiving the recommended mammography screening in the year following treatment compared to Whites (OR 0.5; 95 % CI, 0.2–0.9). Regardless of ethnicity–language, seeing both a specialist and primary care physician increased the odds of mammography screening and CBE (OR 1.6; 95 % CI, 1.2–2.3 and OR 1.9; 95 % CI, 1.3–2.8), as well as having discussions about exercise, weight, and alcohol use, compared to seeing a specialist only.

Conclusions

Most women reported appropriate surveillance after DCIS treatment. However, our results suggest less adequate follow-up for Spanish-speaking Latinas, possibly due to language barriers or insurance access.

Implications for Cancer Survivors

Follow-up with a primary care provider in addition to a breast specialist increases receipt of appropriate follow-up for all women.
Literatur
1.
Zurück zum Zitat Leonard GD, Swain SM. Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst. 2004;96(12):906–20.PubMedCrossRef Leonard GD, Swain SM. Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst. 2004;96(12):906–20.PubMedCrossRef
2.
Zurück zum Zitat Virnig BA, et al. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010;102(3):170–8.PubMedCrossRef Virnig BA, et al. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010;102(3):170–8.PubMedCrossRef
3.
Zurück zum Zitat Morrow M, et al. Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin. 2002;52(5):256–76.PubMedCrossRef Morrow M, et al. Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin. 2002;52(5):256–76.PubMedCrossRef
4.
Zurück zum Zitat Kerlikowske K, et al. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J Natl Cancer Inst. 2003;95(22):1692–702.PubMedCrossRef Kerlikowske K, et al. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J Natl Cancer Inst. 2003;95(22):1692–702.PubMedCrossRef
5.
Zurück zum Zitat Wang SY, et al. Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Breast Cancer Res Treat. 2011;127(1):1–14.PubMedCrossRef Wang SY, et al. Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Breast Cancer Res Treat. 2011;127(1):1–14.PubMedCrossRef
6.
Zurück zum Zitat Kane RL, et al. The impact of surgery, radiation, and systemic treatment on outcomes in patients with ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010;2010(41):130–3.PubMedCrossRef Kane RL, et al. The impact of surgery, radiation, and systemic treatment on outcomes in patients with ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010;2010(41):130–3.PubMedCrossRef
7.
Zurück zum Zitat Claus EB, et al. The risk of a contralateral breast cancer among women diagnosed with ductal and. Breast. 2003;12:451–6.PubMedCrossRef Claus EB, et al. The risk of a contralateral breast cancer among women diagnosed with ductal and. Breast. 2003;12:451–6.PubMedCrossRef
8.
Zurück zum Zitat Li CI, et al. Risk of invaive breast carcinoma among women diagnosed wth ductal carcinoma in situ and lobular carcinoma in situ, 1988–2001. Cancer. 2006;106:2104–12.PubMedCrossRef Li CI, et al. Risk of invaive breast carcinoma among women diagnosed wth ductal carcinoma in situ and lobular carcinoma in situ, 1988–2001. Cancer. 2006;106:2104–12.PubMedCrossRef
9.
Zurück zum Zitat Innos K, Horn-Ross PL. Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2008;111(3):531–40.PubMedCrossRef Innos K, Horn-Ross PL. Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2008;111(3):531–40.PubMedCrossRef
10.
Zurück zum Zitat Khatcheressian JL, et al. American society of clinical oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24(31):5091–7.PubMedCrossRef Khatcheressian JL, et al. American society of clinical oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24(31):5091–7.PubMedCrossRef
12.
Zurück zum Zitat George SM, et al. Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and prognosis after early-stage breast cancer. Cancer Causes Control. 2011;22(4):589–98.PubMedCrossRef George SM, et al. Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and prognosis after early-stage breast cancer. Cancer Causes Control. 2011;22(4):589–98.PubMedCrossRef
13.
Zurück zum Zitat Bertram LA, et al. Physical activity, additional breast cancer events, and mortality among early-stage breast cancer survivors: findings from the WHEL Study. Cancer Causes Control. 2011;22(3):427–35.PubMedCrossRef Bertram LA, et al. Physical activity, additional breast cancer events, and mortality among early-stage breast cancer survivors: findings from the WHEL Study. Cancer Causes Control. 2011;22(3):427–35.PubMedCrossRef
14.
Zurück zum Zitat Sternfeld B, et al. Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study. Cancer Epidemiol Biomarkers Prev. 2009;18(1):87–95.PubMedCrossRef Sternfeld B, et al. Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study. Cancer Epidemiol Biomarkers Prev. 2009;18(1):87–95.PubMedCrossRef
15.
Zurück zum Zitat Kwan ML, et al. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol. 2010;28(29):4410–6.PubMedCrossRef Kwan ML, et al. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol. 2010;28(29):4410–6.PubMedCrossRef
16.
Zurück zum Zitat Holmes MD, et al. Physical activity and survival after breast cancer diagnosis. JAMA. 2005;293(20):2479–86.PubMedCrossRef Holmes MD, et al. Physical activity and survival after breast cancer diagnosis. JAMA. 2005;293(20):2479–86.PubMedCrossRef
17.
Zurück zum Zitat Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol. 2002;20(4):1128–43.PubMedCrossRef Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol. 2002;20(4):1128–43.PubMedCrossRef
18.
Zurück zum Zitat Li CI, et al. Epidemiologic and molecular risk factors for contralateral breast cancer among young women. Br J Cancer. 2003;89(3):513–8.PubMedCrossRef Li CI, et al. Epidemiologic and molecular risk factors for contralateral breast cancer among young women. Br J Cancer. 2003;89(3):513–8.PubMedCrossRef
19.
Zurück zum Zitat Nekhlyudov L, et al. Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery. J Clin Oncol. 2009;27(19):3211–6.PubMedCrossRef Nekhlyudov L, et al. Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery. J Clin Oncol. 2009;27(19):3211–6.PubMedCrossRef
20.
Zurück zum Zitat Kagay CR, Quale C, Smith-Bindman R. Screening mammography in the American elderly. Am J Prev Med. 2006;31(2):142–9.PubMedCrossRef Kagay CR, Quale C, Smith-Bindman R. Screening mammography in the American elderly. Am J Prev Med. 2006;31(2):142–9.PubMedCrossRef
21.
Zurück zum Zitat Wells KJ, Roetzheim RG. Health disparities in receipt of screening mammography in Latinas: a critical review of recent literature. Cancer Control. 2007;14(4):369–79.PubMed Wells KJ, Roetzheim RG. Health disparities in receipt of screening mammography in Latinas: a critical review of recent literature. Cancer Control. 2007;14(4):369–79.PubMed
22.
Zurück zum Zitat Whitman S, et al. Mammography screening in six diverse communities in Chicago—a population study. Cancer Detect Prev. 2007;31:166–72.PubMedCrossRef Whitman S, et al. Mammography screening in six diverse communities in Chicago—a population study. Cancer Detect Prev. 2007;31:166–72.PubMedCrossRef
23.
Zurück zum Zitat González P, Borrayo EA. The role of physician involvement in Latinas’ mammography screening adherence. Women’s Health Issues. 2010;21(2):165–70.CrossRef González P, Borrayo EA. The role of physician involvement in Latinas’ mammography screening adherence. Women’s Health Issues. 2010;21(2):165–70.CrossRef
24.
Zurück zum Zitat Smith-Bindman R, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006;144(8):541–53.PubMed Smith-Bindman R, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006;144(8):541–53.PubMed
25.
Zurück zum Zitat Mack KP, et al. Adherence to recent screening mammography among Latinas: findings from the California Women’s Health Survey. J Womens Health (Larchmt). 2009;18(3):347–54.CrossRef Mack KP, et al. Adherence to recent screening mammography among Latinas: findings from the California Women’s Health Survey. J Womens Health (Larchmt). 2009;18(3):347–54.CrossRef
26.
Zurück zum Zitat Hollowell K, et al. American society of clinical oncology-recommended surveillance and physician specialty among long-term breast cancer survivors. Cancer. 2010;116(9):2090–8.PubMed Hollowell K, et al. American society of clinical oncology-recommended surveillance and physician specialty among long-term breast cancer survivors. Cancer. 2010;116(9):2090–8.PubMed
27.
Zurück zum Zitat Kaplan CP, et al. Selection of treatment among Latina and non-Latina White women with ductal carcinoma in situ. J Womens Health (Larchmt). 2011;20(2):215–23.CrossRef Kaplan CP, et al. Selection of treatment among Latina and non-Latina White women with ductal carcinoma in situ. J Womens Health (Larchmt). 2011;20(2):215–23.CrossRef
28.
Zurück zum Zitat Sangha O, et al. The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49(2):156–63.PubMedCrossRef Sangha O, et al. The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49(2):156–63.PubMedCrossRef
29.
Zurück zum Zitat Cummings SR, et al. Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst. 2009;101(6):384–98.PubMedCrossRef Cummings SR, et al. Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst. 2009;101(6):384–98.PubMedCrossRef
30.
Zurück zum Zitat Willett WC, et al. Moderate alcohol consumption and the risk of breast cancer. N Engl J Med. 1987;316(19):1174–80.PubMedCrossRef Willett WC, et al. Moderate alcohol consumption and the risk of breast cancer. N Engl J Med. 1987;316(19):1174–80.PubMedCrossRef
31.
Zurück zum Zitat Feigelson HS, et al. Alcohol consumption increases the risk of fatal breast cancer (United States). Cancer Causes Control. 2001;12(10):895–902.PubMedCrossRef Feigelson HS, et al. Alcohol consumption increases the risk of fatal breast cancer (United States). Cancer Causes Control. 2001;12(10):895–902.PubMedCrossRef
32.
Zurück zum Zitat Field TS, et al. Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med. 2008;23(2):158–63.PubMedCrossRef Field TS, et al. Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med. 2008;23(2):158–63.PubMedCrossRef
33.
Zurück zum Zitat Ganz PA, Hahn EE. Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol. 2008;26(5):759–67.PubMedCrossRef Ganz PA, Hahn EE. Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol. 2008;26(5):759–67.PubMedCrossRef
Metadaten
Titel
Ductal carcinoma in situ (DCIS): posttreatment follow-up care among Latina and non-Latina White women
verfasst von
Mónica E. López
Celia P. Kaplan
Anna M. Nápoles
Jennifer C. Livaudais
E. Shelley Hwang
Susan L. Stewart
Joan Bloom
Leah Karliner
Publikationsdatum
01.06.2013
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 2/2013
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-012-0262-6

Weitere Artikel der Ausgabe 2/2013

Journal of Cancer Survivorship 2/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.